Contact
searchSearch
HMP Global

Obesity Topic Center

News
Semaglutide Promotes Fat Loss While Preserving Muscle Function in Severe Obesity
03/13/2026
Lisa Kuhns, PhD, MD
A real-world study suggests semaglutide not only drives meaningful weight loss but may also improve muscle strength and reduce sarcopenic obesity in patients with severe obesity.
A real-world study suggests semaglutide not only drives meaningful weight loss but may also improve muscle strength and reduce sarcopenic obesity in patients with severe obesity.
A real-world study suggests...
03/13/2026
First Report Managed Care
News
NHANES Data Highlight Growing Severe Obesity Burden in US Adults
03/05/2026
Grace Taylor, MS, MA
New National Health and Nutrition Examination Survey (NHANES) data show that more than 40% of U.S. adults have obesity, with severe obesity continuing to rise and persistent disparities across age, sex, and racial groups.
New National Health and Nutrition Examination Survey (NHANES) data show that more than 40% of U.S. adults have obesity, with severe obesity continuing to rise and persistent disparities across age, sex, and racial groups.
New National Health and...
03/05/2026
First Report Managed Care
News
Weight and Emotions Scale Validated in US Adults With Obesity
02/13/2026
Juliet Gallagher
A newly developed patient-reported outcome (PRO) instrument—the Weight and Emotions Scale (WES)—demonstrated strong content validity in US adults with obesity or overweight. Developed in alignment with US Food and Drug Administration guidance...
A newly developed patient-reported outcome (PRO) instrument—the Weight and Emotions Scale (WES)—demonstrated strong content validity in US adults with obesity or overweight. Developed in alignment with US Food and Drug Administration guidance...
A newly developed...
02/13/2026
First Report Managed Care
News
New Obesity Definition Expands Risk Identification Beyond BMI Alone
02/10/2026
Grace Taylor, MS, MA
A revised obesity framework that goes beyond body mass index (BMI) alone captures a significantly larger share of US adults with elevated risk for metabolic disease, cardiovascular events, and mortality.
A revised obesity framework that goes beyond body mass index (BMI) alone captures a significantly larger share of US adults with elevated risk for metabolic disease, cardiovascular events, and mortality.
A revised obesity framework that...
02/10/2026
First Report Managed Care
Conference Coverage
Exercise Boosts Daily Activity Beyond Workouts in Older Adults With Obesity, Study Finds
11/06/2025
Grace Taylor, MS, MA
A study presented at ObesityWeek 2025 shows that adding structured exercise to calorie-restricted weight loss plans significantly increases daily, non-exercise physical activity in older adults with obesity.
A study presented at ObesityWeek 2025 shows that adding structured exercise to calorie-restricted weight loss plans significantly increases daily, non-exercise physical activity in older adults with obesity.
A study presented at ObesityWeek...
11/06/2025
First Report Managed Care
Conference Coverage
GLP-1 RA Access Improved Through Specialty Pharmacy Collaboration
11/05/2025
Hannah Musick
A quality improvement initiative demonstrated that partnering with an integrated specialty pharmacy significantly increased GLP-1 RA prescription fulfillment and patient enrollment in a pediatric obesity clinic, streamlining access and...
A quality improvement initiative demonstrated that partnering with an integrated specialty pharmacy significantly increased GLP-1 RA prescription fulfillment and patient enrollment in a pediatric obesity clinic, streamlining access and...
A quality improvement initiative...
11/05/2025
First Report Managed Care
Conference Coverage
Oral GLP-1 Receptor Agonist Bofanglutide Shows Promising Results
11/05/2025
Hannah Musick
Oral bofanglutide demonstrated favorable safety, dose-dependent exposure, and meaningful weight reduction over 14 days, supporting its potential as a once-daily GLP-1 receptor agonist therapy for type 2 diabetes and obesity.
Oral bofanglutide demonstrated favorable safety, dose-dependent exposure, and meaningful weight reduction over 14 days, supporting its potential as a once-daily GLP-1 receptor agonist therapy for type 2 diabetes and obesity.
Oral bofanglutide demonstrated...
11/05/2025
First Report Managed Care
News
GLP-1 Receptor Agonists Linked to Reduced Unhealthy Alcohol Use Among Veterans With Type 2 Diabetes
11/04/2025
Grace Taylor, MS, MA
A study presented at ObesityWeek by the Veterans Health Administration found that patients with type 2 diabetes taking GLP-1 receptor agonists showed significantly lower rates of unhealthy alcohol use, suggesting potential behavioral benefits...
A study presented at ObesityWeek by the Veterans Health Administration found that patients with type 2 diabetes taking GLP-1 receptor agonists showed significantly lower rates of unhealthy alcohol use, suggesting potential behavioral benefits...
A study presented at ObesityWeek...
11/04/2025
First Report Managed Care
Conference Coverage
GLP-1 Receptor Agonists Linked to Lower Mortality and Increased Transplant Waitlisting in Dialysis Patients With Diabetes
11/04/2025
Hannah Musick
In a national cohort study presented at ObesityWeek 2025, GLP-1 receptor agonist use in dialysis patients with type 2 diabetes was associated with lower mortality, greater weight loss, and increased likelihood of transplant waitlisting,...
In a national cohort study presented at ObesityWeek 2025, GLP-1 receptor agonist use in dialysis patients with type 2 diabetes was associated with lower mortality, greater weight loss, and increased likelihood of transplant waitlisting,...
In a national cohort study...
11/04/2025
First Report Managed Care
News
Long-Term Study Reveals Sustained Metabolic Adaptation After Gastric Bypass Surgery
10/21/2024
Lisa Kuhns, PhD, MD
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the...
10/21/2024
First Report Managed Care
Industry Insights
News

Current Issue

Oct/Nov/Dec Volume 22, Issue 4, First Report Managed Care
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use